• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fredun Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5269.0
  • ISIN : INE194R01017
1,368.40 -23 (-1.62%)
  • As on 24 Oct 2026 (EOD)

  • Today’s Low

    1,315.80

  • Today’s High

    1,398.90

  • Open

    1,398.90

  • Perv Close

    1,391.00

  • 52W Low

    1,195.20

  • 52W High

    1,665.00

Key Indicators

  • P/E(TTM)

    50.92

  • Mar.Cap (₹Cr.)

    2,263.07

  • Div & Yield %

    0.02

  • Book Value(₹)

    163.14

  • Debt-Equity Ratio

    -1.62

  • AGM Date

    23-Oct-2026

  • EPS

    26.87

  • P/E Ratio

    50.92

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    2,263.07

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.54

  • BV (₹)

    163.10

  • Sales( ₹ in Cr.)

    635.47

  • NP (in Cr.)

    33.21

  • NP Var(%)

    60.0

  • Div%

    7.0

  • CPS (₹)

    24.90

  • EPS (₹)

    20.10

  • Traded Value (₹ in Lakhs)

    2,262.57

  • 52 Week High

    1,665.00

  • 52 Week Low

    1,195.20

  • Price BSE

    1368.0

  • Price NSE

    1,368.00

  • Market Capital( in Cr.)

    2,262.57

  • P/C Ratio

    55.00

  • P/E Ratio

    68.10

  • Price Vs.BV

    20.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 635.47 453.82 348.16 274.68 224.46 133.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 635.47 453.82 348.16 274.68 224.46 133.89
Other Income 3.66 2.45 0.92 1.82 1.63 1.40
Stock Adjustments 31.69 -6.05 22.44 37.72 0.01 -1.17
Total Income 670.82 450.22 371.52 314.22 226.10 134.12
EXPENDITURE :            
Raw Materials 480.76 321.89 282.42 245.57 176.45 100.60
Power and Fuel Cost 5.35 4.79 4.03 3.17 3.68 3.32
Employee Cost 32.94 22.23 12.50 11.54 10.66 8.66
Other Manufacturing Expenses 17.66 17.17 11.68 8.08 6.59 3.87
Selling and Administration Expenses 36.72 26.42 20.77 14.55 12.76 7.80
Miscellaneous Expenses 2.59 2.63 1.22 1.71 0.46 0.28
Employee Benefit Expenses 32.94 22.23 12.50 11.54 10.66 8.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 576.02 395.12 332.61 284.62 210.60 124.54
Operating Profit 94.80 55.10 38.90 29.60 15.50 9.58
Interest 39.30 22.38 13.65 9.28 4.74 4.37
Gross Profit 55.50 32.72 25.25 20.32 10.76 5.21
Depreciation 7.91 4.45 3.80 2.81 2.16 2.00
Profit Before Tax 47.59 28.27 21.45 17.51 8.60 3.21
Current Tax 12.31 7.12 5.54 4.29 2.21 0.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.06 0.35 0.29 2.41 0.05 0.44
Reported Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Adjustment below Net Profit 0.17 -0.34 -0.07 0.05 0.02 0.00
P & L Balance brought forward 63.91 43.77 28.55 18.00 11.93 10.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.33 0.33 0.33 0.31 0.28 0.27
P & L Balance carried down 96.95 63.91 43.77 28.55 18.00 11.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 7.00 7.00 7.00 7.00 7.00 7.00
Dividend Per Share(Rs) 0.70 0.70 0.70 0.70 0.70 0.70
Earnings Per Share-Unit Curr 60.68 44.07 33.25 23.84 14.29 5.05
Earnings Per Share(Adj)-Unit Curr 20.23 14.69 11.08 7.95 4.76 1.68
Book Value 483.87 299.47 255.15 194.27 153.07 107.96
Book Value(Adj)-Unit Curr 161.29 99.82 85.05 64.76 51.02 35.99

Shareholding Pattern

  • Promoter Group

    43.62%

  • Public Share Holding

    56.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,371,159 43.62 7,371,159 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,371,159 43.62 7,371,159 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 225,000 1.33 225,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 116,977 0.69 116,977 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 291 0.00 291 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 355,329 2.10 259,329 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 697,597 4.13 601,597 15
2] Non Institution
Bodies Corporate 591,901 3.50 493,801 122
Clearing Members 11,627 0.07 11,627 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 388,914 2.30 388,914 347
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 219,247 1.30 219,247 254
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,574,606 21.15 3,454,606 49
Individuals holding nominal share capital up to Rs. 1 lakh 3,733,039 22.09 3,607,570 12,671
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,830,913 52.25 8,484,244 13,484
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,899,669 100.00 16,457,000 13,502

Company Background

Fredun Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Fredun Pharmaceuticals Ltd
  • BSE Code : 5269.0
  • ISIN : INE194R01017

  • Incorporation Year

    1987

  • Registered Office

    26 Manoj Industrial Premises
    G D Ambedkar Marg Wadala, Mumbai,
    Maharashtra-400031

  • Telephone

    91-22-40318111

  • FAX

  • Chairman

    Daulat N Medhora

  • Managing Director

    Daulat N Medhora

  • Company Secretary

    Vaishnavi Rajkamal Sahu

  • Auditor

    R.H. Nisar & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Fredun Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fredun Pharma 1,368.10 639.12 635.47 50.92 21.28
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77